chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Approx 1/2 hr p/immun, pt devel bright red rash on cheeks, chest, & legs; became irritable, p140, R32 crying no resp distress; tried to contact MD x 30min w/phone busy; mom decided to take pt to MD office; Seen by MD told no more Pertussis;
Came into the pharmacy on 9/16/18 stating that she has a rash that is not elevated below her breasts and lower abdomen. It itches and there is nothing oozing from the rash. She also stated that she has eczema. I ask referred her to her current dermatologist since she fills no prescriptions at our pharmacy and wasn't sure if perhaps there was a flare up with eczema. I also recommended Calamine lotion.
This spontaneous report as received from a pharmacist refers to a 84 year old female patient. No medical history or concurrent conditions were reported. On 29-MAR-2013 the patient was vaccinated with ZOSTAVAX, 0.65 ml, subcutaneously. Lot number was reported as 0170AE with an expiration date on 06-MAR-2013. It was reported that the patient was administered with an expired dose of ZOSTAVAX. No adverse effect has been observed or was reported. No additional information is currently available. Additional information is not expected.
Patient described onset of trouble breathing, tactile temperature, bilateral arm pain with tingling in the hands, throat and chest tightness, and dizziness beginning in the evening after she had received her shots in the afternoon.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 01-NOV-2015, the patient was inoculated with the ZOSTAVAX vaccine as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot number not provided). The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 01-AUG-2016, the patient was treated for a blistering vesicular outbreak, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX vaccine for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Patient fully vaccinated with Moderna on 1/29/21 and 2/26/21 presented to ED with complaints of increasing shortness of breath, weakness, and confusion. Patient was admitted to hospital for additional care on 11/1/21. Discharged 11/3/21.
This male subject was enrolled in the prophylactic study 112957 (HIB-097).  On 28 March 2011, he received the 1st dose of HIBERIX (IM R thigh), PEDIARIX (IM L thigh), Wyeth's PREVNAR 13 (IM L thigh or deltoid) and ROTARIX (po).  On 11 April 2011, 14 days after the 1st dose of PEDIARIX, 14 days after the 1st dose of ROTARIX, 14 days after the 1st dose of HIBERIX, 14 days after the 1st dose of PREVNAR 13, this two-month-old subject developed seizure.  The subject was hospitalised.  The subject was treated with lorazepam and phenobarbitone.  The event resolved on 11 April 2011.  The investigator considered that there was a reasonable possibility that the seizure may have been caused by PEDIARIX, ROTARIX, HIBERIX and PREVNAR 13.  Investigator Comments : CT head w/o contrast=grossly normal with no acute intracraneal pathology.  Electroencephalogram=normal for stated age.  MRI Brain without and with contrast = Very subtile periventricular white matter T2 hyperintensity is noted.  This likely related to patients age and related to phase of myelination.  No midline shift, mass effect or abnormal enhancement is identified.  11APR2011-MRSA culture- No methicillin resistant staph aureus isolated.  19APR2011-He was doing well at home until after feeding he turned blue around mouth and started grunting, head turned to left side and left arm and leg noted to be stiff.  Taken to Emergency Department where he had one afrebile seizure lasting 20-30 min with left sided stiffness.  He received 3 doses Lorazepam, 1 fluid bolus and 1 loading dose of Phenobarbital, which broke his seizure.  Transferred to PICU for further management and observation.  No further seizure activity.
chest pain fever of 102.0, sore throat, headache, dizziness, weakness tiredness
Patient was administered incorrect Moderna vaccine as the 2nd dose. Patient should of received the Moderna dark blue cap with gray border as the second dose. Pt was given a lower dose of the COVID vaccine recommended for his age and dose in series.
he wasn't feeling really well; chills; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot Number: not reported), via an unspecified route of administration on 15Feb2021 as dose number unknown, single for covid-19 immunization. Medical history included the patient has a pacemaker. The patient concomitant medications were not reported. The patient reported that he got the shot first shot 15Feb2021. He confirms the Pfizer COVID 19 vaccine. He felt good for quite a while then he started getting chills. He may have had some chills before but he was supposed to go up this morning to the drug store and have them run a test to see if had the COVID or if he does not have it. He asked would that test tell him if had the COVID or if this was a reaction from the shot. He has not had fever, he was not sure if he had chills before the vaccine or after but about week after had the vaccine, maybe a little less, he was not feeling really well, he just does not feel up to par. It just so happens he has a pacemaker and he was going to see his doctor for a check up on Thursday of this week and he told them he was not feeling well and they said okay they told him they were going to have him go into the pharmacy this morning and have them run a test to see if he has the COVID virus. He said his main concern was he was going in week from next Monday for the second shot. He asked was there any chance that they will tell him not to get the second shot because he would be due to have the other shot so if he gets that he wanted to know if he would have the same reactions or little bit less. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained. No further information is expected.
7/13/15-< 15 min from MMRV injection (R) thigh with 3-4 cm erythematous slightly raised patch; fussy, no other s/s. Resolved in 2 hours. 7/22/15-On flight, child had febrile seizure lasting 10 min. Taken to ER. X-ray and blood work negative.
Numbness on left side of face at 10 pm. Pain in the left arm staring from the site of injection to the inner side of the left elbow. Difference in facial sensation between bilateral sides. Reported feeling swelling on left-side.
Seen on 14July06 with c/o bump to L clavicle following smallpox vaccination 8 days prior. Tender lymphadenopathy with multiple nodes to L axilla. Seen later in the day by clinic and transferred to ER with possible heat injury. Soldier presented to ER with c/o HA and elevated temperature of 100.8 degrees. C/O generalized muscle cramps, nausea and dry heaves. IV NS given 800cc Toradol, Phenergan and Benadryl given at ER. Admitted as outpatient. Unknown duration.
Didnt hurt much; This is a spontaneous report from a contactable consumer, the parent. A 17-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8734) via an unspecified route of administration in the arm left on 01Apr2021 at 03:45 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 03:45, after the vaccination, the patient was feeling fine and it was easy and fast and didn't hurt much (pain). The adverse event did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures and treatments were not taken as the result of adverse event. The clinical outcome of the event didn't hurt much (pain) was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Unable to sleep the night I received the vaccine, which was Jan. 25, 2021. Fever varying from 99 to 102.3 degrees on Jan. 25, Jan. 26, and one-half day of Jan. 27, 2021.  loss of appetite.
Chronic pain in whole body, cannot get rid of it; Tingling in back, hands, feet; Cannot sleep, is suffering day and night; Received only 1 dose 24-JUL-2022; Burning sensation; Shingles the next day from 1st dose; Age at vaccination 49 years old; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 49-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 24th July 2022, the patient received the 1st dose of Shingrix. On an unknown date, the patient did not receive the 2nd dose of Shingrix. On 24th July 2022, unknown after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced inappropriate age at vaccine administration. On 25th July 2022, the patient experienced shingles. On 28th August 2022, the patient experienced burning sensation. On an unknown date, the patient experienced general body pain, tingling, sleeplessness and incomplete course of vaccination. The patient was treated with prednisone and gabapentin. On an unknown date, the outcome of the shingles, tingling, burning sensation, sleeplessness, inappropriate age at vaccine administration and incomplete course of vaccination were unknown and the outcome of the general body pain was not recovered/not resolved.   It was unknown if the reporter considered the shingles, general body pain, tingling, burning sensation and sleeplessness to be related to Shingrix.     Additional Information: GSK Receipt Date: 06-FEB-2023  Reporter's Comments: The reporter was the daughter of the patient. The patient received only one dose of Shingrix into right arm and 1 day after vaccination got shingles. A week later, the patient started having chronic pain in whole body and tingling in back, hands and feet.  The patient went to the doctor and was prescribed Gabapentin and Prednisone. The pain went away for 2 days and on 28th August 2022, the patient was in an extremely hot place, and the pain and burning sensation came back. Until this day (the day of reporting) the patient had pain everywhere and could not get rid of it. The patient could not sleep and was suffering day and night. The patient used all the medication she was given, but nothing was helping her and the next step was injections for her nerves. The reporter consented to follow up. Additional Supportive Information: The patient received a dose of Shingrix at inappropriate age, which led to inappropriate age at vaccine administration. Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination.
Pain at the injection site then swelling and bruising lasted for ~3 weeks then she experienced facial rashes with severe headache, diagnosed shingles attack and treated with valtrex tablets completely resolved now.
HYPOXIA 4/17/2022 ATRIAL FIBRILLATION, UNSPECIFIED HYPOXIA 4/17/2022 DYSPHAGIA    ESOPHAGEAL DYSKINESIA HYPOXIA 4/17/2022 RIGHT FEMORAL NECK GARDEN 1 FX INIT
Woke up the next morning with arm swollen and red. The day after the swollen and red traveled past my elbow so I went to the doctor's weekend clinic who diagnosed it as cellulitis and prescribed cephalexin. The next day after the taking the medication the swelling and redness went away.
BODY ACHES; TIREDNESS; This spontaneous report received from a consumer concerned a 55 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A and expiry: UNKNOWN) dose was not reported, administered on 01-APR-2021 for prophylactic vaccination.  No concomitant medications were reported. On 01-APR-2021, the subject experienced body aches. On 01-APR-2021, the subject experienced tiredness. Laboratory data (dates unspecified) included: Blood group B (NR: not provided) B POSITIVE. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, and tiredness on 02-APR-2021. This report was non-serious. This case, from the same reporter is linked to 20210452044, 20210451285 and 20210451655.
Two weeks after I received my vaccination, I got "covid arm." My arm has swelled up, it is red, scaly, and itchy, and is hot to the touch. It is near the site of the injection.
Information has been received from a nurse concerning her 17 year old daughter who three years ago, in April 2007 was vaccinated with doses of GARDASIL IM.  One year after vaccination, in April 2008, the patient gained 25 lbs.  One year later, in April 2009, the patient gained another 25 lbs.  The patient sought unspecified medical attention.  She had been diagnosed with insulin resistance.  At the time of the report, the patient had not recovered.  No further information is available.
Redness, swelling, heat at site of INFLUENZA vaccine given on 3/6/12. Given Rx: AUGMENTIN x 10 days.
AFTER ADMINISTERING VACCINE SAW ON PT CARD THAT THEIR FIRST DOSE HAD BEEN MODERNA ADMINISTERED AT A DIFFERENT PHARMACY.    1ST DOSE WAS MODERNA 006C21A, GIVEN  1014, ON 5/17/2021
Patient described pain in right shoulder at the time of vaccination. She rated the pain a "5" on a 1-10 scale, with "10" being the worse pain. The vaccination site was examined and appeared normal. The injection site was appropriately placed. There were no acute signs of inflammation or allergic-type reaction. The patient was provided an ice pack to her shoulder and acetaminophen 650mg orally. Symptoms were relieved and she was released to home with her husband, who was the driver.
Patient became light headed and hot minutes after receiving shot. Had child lay down with 2 chairs and raised her legs. Provided water to child. Child left pharmacy with mother when she felt better.
Pt recvd vax 1JUL93 & exp rash began to spread to arms & trunk; c/o lips swelling; seen by MD;
I received the first does of the Pfizer vaccine and within 24 hours had started developing a superficial thrombophlebitis on the inside calf of my left leg. By Sunday, February 28th, I was in the emergency room getting an ultrasound to rule  out a blood clot. By March 11, I had developed a DVT. I have been put on blood thinner and had catscans, ultra sounds, and am under a physician's care weekly.
passed out  VOMITING DIDN'T TAKE TYLENOL couldn't open mouth PRESSURE TOP OF HEAD
Pt received PPV23 in (L) deltoid, next day site was red, swollen, warm and tender. Sx worse on following day and pt went to ER. Dx cellulitis. Tx with 1 dose IV ROCEPHIN 1000 mg and discharged with rx for KEFLEX 500 mg x 7 days. Sx resolved.
a patient who is pregnant received GARDASIL 9; This spontaneous prospective pregnancy report was received from a company representative and refers to a female patient of unknown age. The patient's relevant medical history, concomitant medications, concurrent conditions and allergies were unknown.  On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) for prophylaxis (dose, strength, frequency, route of administration, lot# and expiration date were unknown).       The patient became pregnant on an unknown date and then received hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (exposure during pregnancy). The last menstrual period LMP and estimated date of delivery EDD were not known. The pregnancy outcome was unknown.The outcome of exposure during pregnancy was unknown.
This case was reported by a consumer via call center representative and described the occurrence of adverse event in a patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced adverse event. On an unknown date, the outcome of the adverse event was unknown. It was unknown if the reporter considered the adverse event to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient had been ill with the side effects for 48 hours now. The patient had everything listed except upset stomach.
Missing date of 1997 vaccination.  Reported acute hearing loss 6 hours after vaccinated now (2008) requiring hearing aide.  Symptoms: Hearing loss.  10/14/08 Reviewed medical records of 8/26/08. FINAL DX: sensorineural hearing loss left ear  Records reveal patient experienced complete hearing loss of left ear 6 hrs s/p 1997 influenza vaccine.
The evening of the vaccine, I had a very small red mark at the injection site. Throughout the next week it stayed about the size of a nickel and was very warm. Saturday night it almost doubled in size and was swollen and about 102 degree surface temp. Sunday morning 2/14, it was very swollen and larger as well as hot still. Today 2/15, it is very large (3") and 103 degree surface temp. It is starting it itch and throb.
I started to get sick and thought it was allergies around Christmas time. I was trying to treat it myself and nothing was working. I started to cough some and then my appetite was gone. Food made me nauseous. After Christmas, I had stopped eating and the headaches started. The headaches were so bad I could not see. I also started to have trouble breathing. My husband took me to emergency room on January 1st 2022. My oxygen levels were so low I was given oxygen. I took a COVID test at the hospital and it came back positive. They started right away to treat my COVID and I started to feel better after that. The COVID was exacerbating my COPD. After about a week, I was able to breathe better, lost my fever, gained my appetite back. I was released from the the hospital after one week. I continue to see a pulmonologist and have been on oxygen since leaving the hospital. Before getting COVID, I only had to use oxygen at night time. I also found out while I was hospitalized that I am now a type 2 diabetic.
Patient call primary care provider on 1/20/2021 at 3:00 pm and stated that she had redden and swelling of face with itching of head, neck back, face.  Instructed to take Benadryl 50 mg. and 25 mg every 6 hours.  Patient call next morning 1/21/2021 stated much better, believes it was from new face cream she tried.
Triggered migraines, couldn?t eat, Vomiting nausea diarrhea dehydration UTI kidney infection ended up in the hospital for five days
I had my vaccine at 1230 pm on Monday Dec 28th. At approx 430am Tuesday am, I awoke with a bad stomach ache.  By 9am, i had uncontrollable chills, followed by body pain, stiffness, extreme weakness. By 11a, I had a temp of 103.3.  This lasted approx 8 hours. Fever broke and a bad headache, chest wall and mid back discomfort along with muscles twitching, leg cramping and fatigue. Dec. 31st, doing better, but still fatigue, weakness, muscle twitching, headache.
it was warm and raised; A large lymph node above her collar bone; an itchy spot the size of a quarter; the rash started again; supraclavicular lymphadenopathy; an itchy spot the size of a quarter; sore arm; flu like symptoms; A spontaneous report  was received from a female consumer of an unknown who received Moderna's COVID-19 Vaccine, and who experienced being mild sore arm, itchy spot the size of a quarter that night (reported in case MOD-2021-01036), flu-like symptoms, low grade temperature that went away and then came back, a large area on my shoulder, it was warm and raised.and a supraclavicular lymphadenopathy.  The patient's medical history was not provided. Concomitant medications were not provided by the reporter.   The patient received her first of two planned doses of mRNA-1273 (LOT number not provided) on an unspecified day last week intramuscularly in the for prophylaxis of COVID-19 infection.  On 05 Jan 2021, a female patient reported that after she received her first of the Moderna COVID-19 vaccination last week, she experienced being mild sore, had a low-grade temperature that went away and then came back, and had a large lymph node above her collar bone.  On that day, she was seen by her health care professional (HCP).   Treatment for the events were not provided.  At the time of the report no additional information was provided.  Action taken with mRNA-1273 in response to the events was unknown.   The outcome for the events, being mild sore arm, itchy spot the size of a quarter that night (reported in case MOD-2021-01036), flu-like symptoms, low grade temperature that went away and then came back, a large area on my shoulder, it was warm and raised. and a supraclavicular lymphadenopathy.were unknown.   The causality assessment was not provided by the reporter.; Reporter's Comments: This case concerns a 48-year-old female who had NS events of unexpected influenza like illness, injection site warmth, pain in extremity, and expected injection site pruritus, injection site rash, injection site swelling, lymphadenopathy. Event onset the same day as first dose mRNA-1273. Treatment not reported. Outcomes unknown. Based on current available information and temporal association between use of the product and the start date of the event, a causal relationship cannot be excluded.
Case number PHEH2014US019163, is an initial spontaneous report received from a nurse on 19 Sep 2014. This report refers to a 53-year-old female patient. Past medical history and concomitant medication was not reported. On 18 Sep 2014, the patient was inadvertently vaccinated with FLUVIRIN (batch number: 1412001) intramuscularly at a dose of 1.0 ml instead of the recommended 0.5 ml dose. No adverse event was reported following this medication error (overdose).
Delayed reaction at injection site: itching, redness, swelling, warmth. 4-5 inches in diameter. Appeared  10 days after injection., increased in size for several days. 14 days after injection it is still here but beginning to fade.
R57.1 HYPOVOLEMIC SHOCK 2/7/2023 METABOLIC ACIDOSIS, UNSPECIFIED R57.1 HYPOVOLEMIC SHOCK 2/7/2023 GI HEMORRHAGE
Pt with 10cm reaction within tattoo on L shoulder. rash, papules & pustules within tattoo area only.
Initial report received on 16/Nov/2005 from a health care professional. A 19 year old male patient with no significant medical history had received his first intra-muscular injection of Menactra, lot number U1860AA, in the left arm on 07/Nov/2005. Seven days later, on 14/Nov/2005, he presented with a generalized macular rash and itching that was treated orally with Benadryl. The next day, the patient contracted the health center complaining of swelling of the lips and hands. The patient denied having any associated respiratory problems or shortness of breath. He saw his primary care physician who determined the patient's diagnosis to be reaction to Menactra vaccine. The patient's recovery status was not reported. Follow-up information received on 26/Jan/2006. Per the reporter, the patient's symptoms resolved during Solumedrol dose pack. No further complaints of any residual symptoms by the patient on 24/Jan/2006 when the reporter spoke with the patient. No further information is expected.